Alx Oncology Holdings ALXO Ratios (2019-2026)

NASDAQ ALXO
$2.03 0.00 (-0.25%)
As of: Sep 4, 2026 · 12:46 PM EDT
Reported Financials

Alx Oncology Holdings Quarterly Ratios

Periods 29 quarters
Latest Jun 2026

Alx Oncology Holdings ratios data for the quarter ended Jun 2026. These financial ratios cover 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
EBIT Margin
EBITDA Margin
Operating Margin
Net Margin
FCF Margin
Efficiency
Assets AverageAssets Avg.
410.51M389.96M371.93M354.85M331.85M312.09M292.31M262.04M233.02M231.33M227.60M213.63M200.17M166.75M134.34M108.11M89.02M70.88M118.69M169.57M
Invested CapitalInvested Cap.
364.68M318.84M289.72M274.50M251.82M222.20M178.33M199.35M173.90M169.09M146.64M123.52M98.27M74.45M54.91M35.73M1,008.51M145.89M
Asset Utilization RatioAsset Util.
Leverage & Solvency
Interest Coverage RatioInterest Cover
-0.01M-0.02M-0.02M-139.48-83.21-98.86-136.25-115.72-88.44-96.79-73.02-71.69-78.37-65.80-55.23-60.11-57.30-63.27
Debt Ratio
0.000.010.010.040.040.040.040.040.050.050.050.070.080.110.120.170.050.06
Times Interest Earned
-0.01M-0.02M-0.02M-139.48-83.21-98.86-136.25-115.72-88.44-96.79-73.02-71.69-78.37-65.80-55.23-60.11-57.30-63.27
Valuation
Price to EarningsP/E
-121.73-30.67-27.10-9.57-11.04-15.03-5.80-8.24-3.87-16.37-14.59-7.52-3.13-3.04-1.02-0.85-4.43-2.69-10.74-17.02
Price to BookP/B
7.762.402.001.041.361.750.771.451.173.923.411.990.700.780.370.342.192.370.212.10
Enterprise Value
2,605.17M508.55M370.50M16.26M105.05M194.30M-43.24M95.02M7.52M561.05M403.15M159.57M-52.58M-39.16M-64.73M-57.38M37.42M16.67M69.87M147.88M
EV to EBIT
-106.00-17.86-14.97-0.48-2.86-6.031.34-2.58-0.14-11.68-10.68-3.841.611.282.032.15-1.66-0.72-3.68-8.20
EV to EBITDA
-106.00-17.86-14.97-0.48-2.86-6.031.34-2.58-0.14-11.68-10.68-3.841.611.282.032.15-1.66-0.72-3.68-8.20
Market Capitalization
2,990.32M872.22M687.10M329.63M389.96M460.51M184.70M307.85M197.53M743.79M560.59M316.29M95.99M88.60M33.10M21.94M98.05M61.46M210.19M286.11M
Price to FCFP/FCF
-118.41-49.14-32.31-19.10-12.55-21.87-6.48-9.20-6.62-18.68-14.72-11.87-3.76-2.76-1.34-0.94-5.72-3.23-11.24-17.80
EV to FCF
-103.16-28.65-17.42-0.94-3.38-9.231.52-2.84-0.25-14.09-10.59-5.992.061.222.622.45-2.18-0.88-3.74-9.20
EV to CFO
-104.81-29.08-17.92-0.96-3.40-9.401.55-3.00-0.24-14.14-10.63-6.012.071.222.622.45-2.19-0.88-3.75-9.21
Return Ratios
Return on Sales [ROS]ROS
Return on Capital Employed [ROCE]ROCE
-18.32%-22.30%-26.38%-33.72%-40.34%-44.91%-49.88%-56.40%-78.07%-87.17%-90.00%-103.08%-95.26%-96.10%-118.11%-136.28%-182.08%-224.51%-92.55%-53.33%
Return on Invested Capital [ROIC]ROIC
Return on Assets [ROA]ROA
-15.59%-21.41%-25.45%-31.79%-37.24%-40.29%-45.24%-51.58%-64.73%-71.60%-75.67%-82.81%-78.25%-84.17%-99.98%-109.33%-123.15%-145.73%-76.24%-47.97%